Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2004
06/23/2004CN1507493A Biosynthetic genes for butenyl-spinosyn insecticide production
06/23/2004CN1506880A Sequence display method and homologous searching method for convenient for accessing relative information to mutation zone and similar zone among multi-sequence
06/23/2004CN1506683A Image aligning device and method for biochip making equipment
06/23/2004CN1506471A Nuclein detecting method
06/23/2004CN1506470A Human STR genotype testing kit
06/23/2004CN1506469A PCR kit for testing banana apical tuft virus and its test method
06/23/2004CN1506468A PCR test kit for hygrophilous aeromonad and its test method
06/23/2004CN1506467A SCAR marker linked with the acidic character of peach fruit and its application
06/23/2004CN1506466A Method and kit for amplifying nucleic acid of target cell or virus
06/23/2004CN1506460A Method and kit for separating cell particle from sample
06/23/2004CN1154847C Method and apparatus for detection of contaminants
06/23/2004CN1154845C Biodetectors targeted to specific ligands
06/23/2004CN1154844C Multilayer analytical element
06/23/2004CN1154747C Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretrioviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
06/23/2004CN1154738C Noval method for characterization of compounds which stimulate STF-1 expression in pancreatic islet cells
06/23/2004CN1154733C Improved heat-stable DNA polymerase
06/23/2004CN1154731C Gene of hop latent virus and methods for detecting the same
06/23/2004CN1154730C Compounds and methods for diagnosis of tuberculosis
06/23/2004CN1154507C Inhibition of binding of Hox and homeodomain containing proteins and uses thereof
06/22/2004US6753457 Activation of fetal nucleus; obtain cells, separate nucleus, incubate with activating egg extract, monitor fetal nucleus activity
06/22/2004US6753424 Conjugates of DNA interacting groups with steroid hormones for use as nucleic acid transfection agents
06/22/2004US6753423 For preferentially modulated gene expression in liver and associated tissues
06/22/2004US6753422 Odc allelic analysis method for assessing carcinogenic susceptibility
06/22/2004US6753421 Probes for the detection of mycobacteria
06/22/2004US6753419 Used for somatic gene therapy
06/22/2004US6753418 Suppressors of human breast cancer cell growth
06/22/2004US6753417 Peptide for use in the diagnosis and prevention of immunological and infectious disorders
06/22/2004US6753416 Modifications of the VEGF receptor-2 protein and methods of use
06/22/2004US6753412 Human Eag2
06/22/2004US6753324 Phosphorous organic compounds and their use
06/22/2004US6753188 For microscopic analysis
06/22/2004US6753176 Genetic engineering; antiarthritic agents
06/22/2004US6753169 Annealing preferential nucleotide sequences; provide sample and vessel, incubate sample with nucleotide sequences, monitor annealing process
06/22/2004US6753163 Alzheimer's disease secretase, APP substrates therefor, and uses therefor
06/22/2004US6753160 Method of using metaloporphyrins for treatment of arteriosclerotic lesions
06/22/2004US6753159 Uric acid assay device with stabilized uricase reagent composition
06/22/2004US6753157 Monitoring protein activity in sample; conjugate binding protein to peptide substrate, incubate with protein kinase, measure activity of kinase
06/22/2004US6753154 Human AZU-1 gene, variants thereof and expressed gene products
06/22/2004US6753153 Markers for identification and isolation of pancreatic islet α and β progenitors
06/22/2004US6753150 Detection of modulators of advanced glycation end product activity; obtain sample containing advanced glycation end product activity, incubate with peptide monitor adjustment in activity, adjustment in activity indicates modulator
06/22/2004US6753148 Methods and apparatus for detecting variants utilizing base stacking
06/22/2004US6753147 Digital amplification
06/22/2004US6753146 System and method for evaluating agents which prevent oxidative damage
06/22/2004US6753145 Composition for use in high temperature hybridization of oligonucleotides
06/22/2004US6753144 Biochip
06/22/2004US6753141 Detection of nucleotide sequence mutation; obtain nucleotide sequence sample, denature and determine melting temperature, evaluate probe hybridization pattern
06/22/2004US6753140 Nucleotide sequences coding preferential polypeptide for use in the treatment of diabetes and eating disorders
06/22/2004US6753138 Use of prothymosin in the diagnosis and treatment of endometriosis
06/22/2004US6753137 Diagnosing stomach cancer in humans; obtain fluid sample, detect epstein barr virus, the presence of the virus is an indication of stomach cancer
06/22/2004US6753136 Expressing preferential amino acid sequences on surface of viruses; obtain genetically engineered viruses, express amino acid sequences, moniltor viral coat for presence of preferential amino acid sequences
06/22/2004CA2344642C Characterising polypeptides through cleavage and mass spectrometry
06/22/2004CA2276107C Improved substrates for human cytomegalovirus protease
06/22/2004CA2202152C Systems for generating and analyzing stimulus-response output signal matrices
06/22/2004CA2049429C Dna sequencing
06/20/2004CA2453872A1 Heat-labile desoxyribonuclease i variants
06/20/2004CA2453741A1 Method for manufacturing a sterilized and calibrated biosensor-based medical device
06/19/2004CA2423904A1 Haplotype partitioning in the proximal promoter of the human growth hormone (gh1) gene
06/19/2004CA2411264A1 Sequences for detection and identification of the human metapneumovirus
06/17/2004WO2004051774A2 Enzyme immobilization for use in biofuel cells and sensors
06/17/2004WO2004051561A2 Systems and methods for sequence comparison
06/17/2004WO2004051277A1 Flow-through assay devices
06/17/2004WO2004051274A1 Ahemically amplified electrochemical detection of affinity reaction
06/17/2004WO2004051272A1 Method of immobilizing polynucleotide on solid support, solid immobilization support thus obtained, method of detecting target polynucleotide from the solid support and solution for immobilizing polynucleotide
06/17/2004WO2004051259A1 Method of analyzing coenzyme q-10 and two-electron reduction product thereof and analysis system
06/17/2004WO2004051226A2 Monitoring high-risk environments
06/17/2004WO2004051224A2 Multiplexed methylation detection methods
06/17/2004WO2004051222A2 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases
06/17/2004WO2004051218A2 Multiplex amplification of polynucleotides
06/17/2004WO2004051214A2 Use of fluorine nmr for high throughput screening
06/17/2004WO2004050918A1 Method to generate or determine nucleic acid tags corresponding to the terminal ends of dna molecules using sequences analysis of gene expression (terminal sage)
06/17/2004WO2004050917A1 General primers and process for detecting diverse genotypes of human papillomavirus by pcr
06/17/2004WO2004050916A1 Recovery of original template
06/17/2004WO2004050915A1 Determination of methylation of nucleic acid sequences
06/17/2004WO2004050914A1 Cancer associated plexinb1 mutations
06/17/2004WO2004050913A1 Treatment of huntington’s disease with epa
06/17/2004WO2004050912A2 Method and kit for ribonucleoside-specific detection and quantification
06/17/2004WO2004050911A2 Method for lowering both sequence variations and increase of base lines effects in diagnostic hybridisation assay, assay for performing such a method and probe for use in the assay
06/17/2004WO2004050910A1 Method for hybridisation of immobilized genomic dna
06/17/2004WO2004050908A1 An early pre-symptomatic prion diagnostic blood test for encephalopathies
06/17/2004WO2004050907A2 Method for determing predisposition to manifestation of immune system related diseases
06/17/2004WO2004050906A1 Methylation dna detecting method
06/17/2004WO2004050905A1 Eukaryotic biosensor making use of a calcium regulated light emitting enzyme
06/17/2004WO2004050903A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4c (pde4c)
06/17/2004WO2004050902A1 Method for universal detection of micro-organisms and reaction medium therefor
06/17/2004WO2004050899A2 Method for in vitro selection of 2’-substituted nucleic acids
06/17/2004WO2004050898A2 Ampk pathway components
06/17/2004WO2004050895A2 Methods and compositions for inducing apoptosis in cancer cells
06/17/2004WO2004050894A2 Heart failure gene determination and therapeutic screening
06/17/2004WO2004050885A2 Control of apoptosis using a complex of an oligonucleotide and a regulatory peptide
06/17/2004WO2004050870A2 Genetic switches for the detection of fusion proteins
06/17/2004WO2004050854A2 Methods for identifying the activity of gene products
06/17/2004WO2004050842A2 Atm kinase compositions and methods
06/17/2004WO2004050839A2 Fragmentation-based methods and systems for sequence variation detection and discovery
06/17/2004WO2004050837A2 Treatment of dna damage related disorders
06/17/2004WO2004050835A2 Predicting animal performance
06/17/2004WO2004050833A2 Glyceraldehyde 3-phosphate dehydrogenase-s(gapds), a glycolytic enzyme expressed only in male germ cells,is a target for male contraception
06/17/2004WO2004050825A2 Protein synthesis monitoring (psm)
06/17/2004WO2004050682A2 Phosphospecific pak antibodies and diagnostic kits
06/17/2004WO2004050675A1 Concurrent microorganism identification and susceptibilities from broth
06/17/2004WO2004050117A1 Proteins involved in the regulation of energy homeostasis